Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
human induced pluripotent stem cell (hiPSC)-derived cardiomyocyte subtypes and autonomic neurons, as well as 3D tissues such as cardiac assembloids. The successful candidate will play a pivotal role in
-
-022-00951-w Investigating the role of autophagy and mitochondrial function in leukaemic stem cells Supervisors: Vignir Helgason , Eric Kalkman Our lab is interested in biological processes
-
-track faculty member in cell and molecular biology at the rank of Assistant Professor. All research areas in cell and molecular biology will be considered, with a preferred emphasis on stem cell research
-
BBSRC Yorkshire Bioscience DLA Programme: Directing Stem Cell Fate – The Role of Ribosomal RNA Modifications School of Biosciences PhD Research Project Competition Funded Students Worldwide Dr E
-
in this frame: Dr. Alejo Rodríguez-Fraticelli - Quantitative Stem Cell Dynamics Dr. Alexandra Avgustinova - Pediatric Cancer Epigenetics Dr. Angel R. Nebreda - Signalling and Cell Cycle Laboratory Dr
-
Vesicles (2025) 14(8). 5. Inhibition and reversal of a TGF-β1 induced myofibroblast phenotype by adipose tissue-derived paracrine factors. Stem Cell Research & Therapy (2024), 15. 6. Reduced fibroblast
-
include: complex plasmid design and construction; work with bacteriophage; Fluorescence-activated cell sorting (FACS); tissue culture including embryonic stem cell culture, southern and western blotting
-
Université Paris-Saclay GS Santé et médicaments | Chatenay Malabry, le de France | France | about 2 months ago
limited. In addition, animal model not always faithfully reflect the unique features of human biology, disease and also rise ethical concerns. Induced pluripotent stem cell (iPSC) technology has
-
Stem Cells are particularly encouraged to apply. All applicants must demonstrate an alignment with our existing research programmes and ideally be able to strengthen our research through their addition
-
Medicine. Hereditary eye diseases are diagnosed in approximately 100 children annually in the Netherlands. With rapid advances in technologies such as genome editing and induced pluripotent stem cells, new